Zhong Li, Liu Yan, Wang Conglin, Su Lei, Liu Zhifeng, Wu Ming
Department of Medical Critical Care Medicine, General Hospital of Southern Theatre Command of Peoples Liberation Army, Guangzhou, China.
Department of Traditional Chinese Medicine, The First Affiliated Hospital, Guizhou University of Chinese Medicine, Guiyang, China.
Front Med (Lausanne). 2025 Apr 30;12:1514139. doi: 10.3389/fmed.2025.1514139. eCollection 2025.
Limited data are available regarding disseminated intravascular coagulation (DIC) scores after liver transplantation (LT). As Chinese DIC Scoring System (CDSS) is widely accepted for assessing coagulation in China, this study was aimed to investigate the prognostic value of CDSS scores in patients with undergoing LT.
A retrospective cohort study was conducted on patients who underwent LT from November 2009 to October 2021. We validated CDSS criteria by comparing with International Society on Thrombosis and Hemostasis (ISTH) score. Additionally, its prognostic value was evaluated with receiver operating characteristic (ROC) curves and odds ratio based on mortality rates at 28, 60, and 90 days, as well as the correlations between the CDSS score and acute physiological and chronic health assessment II (APACHE II), sequential organ failure assessment (SOFA) scores at 90-day mortality.
A total of 569 LT patients were enrolled, of which 80 patients developed DIC with CDSS score and 305 patients with ISTH score. Patients with DIC using the CDSS exhibited higher APACHE II and SOFA scores than those with ISTH score. The incidences of acute kidney injury, infection, lymphocytopenia and mortality were higher in DIC patients with CDSS than in those with ISTH. When assessing the prognostic value for 28-day mortality, the CDSS demonstrated higher sensitivity (64.61% vs. 50.77%), but lower specificity (73.62% vs. 88.89%) compared to the ISTH, the areas under ROC (AUC) for the CDSS and ISTH scores were 0.739, 0.741 ( < 0.05) and the odds ratios (OR) for the CDSS and the ISTH were 6.228, 3.597, respectively ( < 0.05). The ORs for predicting mortality with 60-day (7.719 vs. 3.95) and 90-day (7.582 vs. 3.95) criteria with CDSS were higher than those with ISTH ( < 0.05). The Spearman's rank correlation coefficients between the CDSS and APACHE II scores, and the SOFA scores were 0.217 and 0.422, respectively, compared to 0.19 and 0.371 for the ISTH score ( < 0.001).
Disseminated intravascular coagulation presents a life-threatening complication in perioperative period of LT. The CDSS score has better prognostic value than the ISTH score for DIC patients after LT. A prospective randomized controlled study should be designed to further evaluate the findings.
关于肝移植(LT)后弥散性血管内凝血(DIC)评分的数据有限。由于中国DIC评分系统(CDSS)在中国被广泛用于评估凝血功能,本研究旨在探讨CDSS评分在LT患者中的预后价值。
对2009年11月至2021年10月接受LT的患者进行回顾性队列研究。我们通过与国际血栓与止血协会(ISTH)评分进行比较来验证CDSS标准。此外,基于28天、60天和90天的死亡率,通过受试者工作特征(ROC)曲线和比值比评估其预后价值,以及CDSS评分与急性生理与慢性健康状况评估II(APACHE II)、90天死亡率时的序贯器官衰竭评估(SOFA)评分之间的相关性。
共纳入569例LT患者,其中80例患者采用CDSS评分诊断为DIC,305例患者采用ISTH评分诊断为DIC。使用CDSS诊断为DIC的患者APACHE II和SOFA评分高于使用ISTH评分的患者。CDSS诊断为DIC的患者急性肾损伤、感染、淋巴细胞减少和死亡率的发生率高于ISTH诊断为DIC的患者。在评估28天死亡率的预后价值时,与ISTH相比,CDSS表现出更高的敏感性(64.61%对50.77%),但特异性较低(73.62%对88.89%),CDSS和ISTH评分的ROC曲线下面积(AUC)分别为0.739、0.741(<0.05),CDSS和ISTH的比值比(OR)分别为6.228、3.597(<0.05)。CDSS预测60天(7.719对3.95)和90天(7.582对3.95)死亡率的OR高于ISTH(<0.05)。CDSS与APACHE II评分和SOFA评分之间的Spearman等级相关系数分别为0.217和0.422,而ISTH评分为0.19和0.371(<0.001)。
弥散性血管内凝血是LT围手术期的一种危及生命的并发症。LT后DIC患者中,CDSS评分比ISTH评分具有更好的预后价值。应设计前瞻性随机对照研究以进一步评估这些发现。